Credit Suisse’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$2.91M Buy
59,198
+22,179
+60% +$1.09M ﹤0.01% 1612
2023
Q4
$1.35M Buy
37,019
+3,589
+11% +$131K ﹤0.01% 2139
2023
Q3
$773K Sell
33,430
-12,188
-27% -$282K ﹤0.01% 2441
2023
Q2
$1.2M Buy
45,618
+13,379
+41% +$351K ﹤0.01% 2252
2023
Q1
$830K Buy
32,239
+8,703
+37% +$224K ﹤0.01% 2430
2022
Q4
$612K Sell
23,536
-2,392
-9% -$62.2K ﹤0.01% 2644
2022
Q3
$741K Buy
25,928
+6,418
+33% +$183K ﹤0.01% 2523
2022
Q2
$480K Buy
19,510
+566
+3% +$13.9K ﹤0.01% 2857
2022
Q1
$1.07M Buy
18,944
+1,597
+9% +$90K ﹤0.01% 2487
2021
Q4
$1.08M Buy
17,347
+2,538
+17% +$157K ﹤0.01% 2538
2021
Q3
$939K Buy
14,809
+2,367
+19% +$150K ﹤0.01% 2624
2021
Q2
$1.03M Sell
12,442
-1,047
-8% -$86.3K ﹤0.01% 2612
2021
Q1
$993K Sell
13,489
-22,264
-62% -$1.64M ﹤0.01% 2582
2020
Q4
$2.59M Buy
35,753
+10,681
+43% +$775K ﹤0.01% 1961
2020
Q3
$1.2M Buy
25,072
+14,879
+146% +$710K ﹤0.01% 2151
2020
Q2
$428K Buy
+10,193
New +$428K ﹤0.01% 2782
2019
Q4
Sell
-27,319
Closed -$592K 3569
2019
Q3
$592K Buy
+27,319
New +$592K ﹤0.01% 2712